On November 18, Professor Shi Yuanyuan, Chairman of Shenzhen Cell Valley, Commercial Director Wei Zheng, and Senior R&D Scientist Dr. Zhu Wenxiang arrived at the Second Affiliated Hospital of Henan University of Science and Technology (hereinafter referred to as "the Second Affiliated Hospital of HAUST") for a strategic cooperation signing ceremony. They were joined by Liu Longzhuang, Member of the Party Leadership Group and Deputy Director of the Luoyang Municipal Health Commission; Li Yunting, Director of the Science and Education Division; Liu Xiaoge, Party Secretary of the Second Affiliated Hospital of HAUST; Xing Jianwu, President of the Hospital; Wang Huirui, Vice President of the Hospital; and Jia Zhiqiang, Director of the Science and Education Division.

During the symposium, Chairman Professor Shi Yuanyuan provided a detailed introduction to the development trends in the cell and gene therapy industry, the company's strategic layout and positioning, major breakthroughs in production and R&D, and clinical applications in research. Subsequently, the two sides engaged in in-depth exchanges and discussions on future cooperation matters, including the coconstruction of a cell preparation center, and formally signed the strategic cooperation agreement.

The signing of this strategic cooperation agreement marks an important step forward for both parties in resource sharing, complementary advantages, and deep integration of industry, academia, and research. Shenzhen Cell Valley will provide comprehensive support for the construction of the cell preparation center at the Second Affiliated Hospital of HAUST, committed to applying advanced cell therapy technologies in clinical treatment, with the goal of offering patients more cuttingedge and effective treatment options and cell products.